Efficacy and Safety of HD-6277, a Novel GPR40 Agonist, in Patients with Type 2 Diabetes-A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 2 Trial

被引：0
|
作者：
Lee, Yong-Ho
Min, Kyungwan
Hong, Jun Hwa
Lim, Soo
Yu, Jaemyung
Chung, Choon H.
Moon, Jun Sung
Won, Jong Chul
Ahn, Chul Woo
Lee, Jie-Eun
Kim, Tae Nyun
Lee, Byung-Wan
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-853-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
853-P
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Efficacy and Safety of Lobeglitazone Monotherapy in Patients with Type 2 Diabetes Mellitus over 24-Weeks: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Trial
    Kim, Sin Gon
    Kim, Doo Man
    Woo, Jeong-Taek
    Jang, Hak Chul
    Chung, Choon Hee
    Ko, Kyung Soo
    Park, Jeong Hyun
    Park, Yong Soo
    Kim, Sang Jin
    Choi, Dong Seop
    PLOS ONE, 2014, 9 (04):
  • [12] Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial
    Ji, Linong
    Lu, Jinmiao
    Gao, Leili
    Ying, Changjiang
    Sun, Jiao
    Han, Jie
    Zhao, Wenhua
    Gao, Yunming
    Wang, Kun
    Zheng, Xin
    Xie, Daosheng
    Ding, Juping
    Zhao, Jiahong
    Yu, Qiang
    Wang, Tong
    DIABETES OBESITY & METABOLISM, 2023, 25 (12): : 3671 - 3681
  • [13] A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ANAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES
    Yang, H. K.
    Lee, S. H.
    Min, K. W.
    Park, S. W.
    Chung, C. H.
    Park, K. S.
    Choi, S. H.
    Song, K. -H.
    Kim, D. -M.
    Lee, M. -K.
    Sung, Y. A.
    Baik, S. H.
    Kim, I. J.
    Cha, B. -S.
    Park, J. H.
    Ahn, Y. B.
    Lee, I. -K.
    Yoo, S. -J.
    Kim, J. T.
    Park, I. B.
    Park, T. S.
    Yoon, K. -H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S149 - S150
  • [14] Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients
    Sakai, Fumihiko
    Suzuki, Norihiro
    Kim, Byung-Kun
    Tatsuoka, Yoshihisa
    Imai, Noboru
    Ning, Xiaoping
    Ishida, Miki
    Nagano, Kaori
    Iba, Katsuhiro
    Kondo, Hiroyuki
    Koga, Nobuyuki
    HEADACHE, 2021, 61 (07): : 1102 - 1111
  • [15] Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients
    Sakai, Fumihiko
    Suzuki, Norihiro
    Kim, Byung-Kun
    Igarashi, Hisaka
    Hirata, Koichi
    Takeshima, Takao
    Ning, Xiaoping
    Shima, Tomoko
    Ishida, Miki
    Iba, Katsuhiro
    Kondo, Hiroyuki
    Koga, Nobuyuki
    HEADACHE, 2021, 61 (07): : 1092 - 1101
  • [16] The Efficacy and Safety of Wenxin Keli in Patients with Frequent Premature Ventricular Contractions: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial
    Hua, Wei
    Gao, Run-Lin
    Zhao, Bu-Chang
    Wang, Jing
    Chen, Xu-Hua
    Cai, Chi
    Zhang, Shu
    CHINESE MEDICAL JOURNAL, 2015, 128 (19) : 2557 - 2564
  • [17] The Efficacy and Safety of Wenxin Keli in Patients with Frequent Premature Ventricular Contractions: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Trial
    Hua Wei
    Gao Run-Lin
    Zhao Bu-Chang
    Wang Jing
    Chen Xu-Hua
    Cai Chi
    Zhang Shu
    中华医学杂志英文版, 2015, 128 (19) : 2557 - 2564
  • [18] Efficacy and Safety of Dichlorphenamide for the Treatment of Periodic Paralysis: a Phase 3 Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial
    Burge, James
    Sansone, Valeria
    McDermott, Michael
    Smith, Patty
    Herr, Barbara
    Tawil, Alrabi
    Pandya, Shree
    Kissel, John
    Ciafaloni, Emma
    Shieh, Perry
    Ralph, Jeffrey
    Amato, Anthony
    Cannon, Stephen
    Trivedi, Jaya
    Barohn, Richard
    Crum, Brian
    Mitsumoto, Hiroshi
    Pestronk, Alan
    Meola, Giovanni
    Conwit, Robin
    Jasek, Mark
    Hanna, Michael
    Griggs, Robert
    NEUROLOGY, 2016, 86
  • [19] Efficacy and Safety of Lobeglitazone Monotherapy in Patients With Type 2 Diabetes Mellitus over 24 Weeks: Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study
    Kim, Sin Gon
    Kim, Doo Man
    Woo, Jeong-Taek
    Jang, Hak Chul
    Chung, Choon Hee
    Ko, Kyung Soo
    Park, Jeong Hyun
    Park, Yong Soo
    Kim, Sang Jin
    Choi, Dong Seop
    DIABETES, 2013, 62 : A284 - A284
  • [20] Multicenter, randomized, double-blind, placebo-controlled, parallel trial comparing the safety and efficacy of rufinamide
    Biton, V
    Rosenfeld, W
    Schachter, S
    Perdomo, C
    Arroyo, S
    ANNALS OF NEUROLOGY, 2005, 58 : S114 - S114
12345